A Novel Randomized Trial Protocol for Evaluating Wound Healing Interventions

BACKGROUND: Randomized controlled trials using complete healing as an endpoint suffer from poor statistical power, owing to the heterogeneity of wounds and their healing trajectories. The Food and Drug Administration (FDA) has recently consulted with expert groups to consider percentage area reducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bull, Richard Hillson, Clements, Donna, Collarte, Agnes Juguilon, Harding, Keith Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Discovery Express
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615036/
https://www.ncbi.nlm.nih.gov/pubmed/37526355
http://dx.doi.org/10.1089/wound.2023.0058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615036/
https://www.ncbi.nlm.nih.gov/pubmed/37526355
http://dx.doi.org/10.1089/wound.2023.0058

Ejemplares similares